Sporotrichosis medical therapy: Difference between revisions
Jump to navigation
Jump to search
| Line 22: | Line 22: | ||
local hyperthermia | local hyperthermia | ||
|Continue treatment for 2-4 weeks | |Continue treatment for 2-4 weeks after lesions resolve. | ||
after lesions resolve. | |||
|- | |- | ||
|Osteoarticular | |Osteoarticular | ||
|Itraconazole [200 mg b.i.d.] | |Itraconazole [200 mg b.i.d.] | ||
| | |Limposomal amphotericin B [3-5 mg/kg/day] or deoxycholate amphotericin B [0.7-1 mg/kg/day] until symptom resolution | ||
| | |For a total of 12 months, switch to itraconazole after resolution/end of treatment. | ||
|- | |- | ||
|Pulmonary | |Pulmonary | ||
Revision as of 15:21, 12 January 2016
|
Sporotrichosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sporotrichosis medical therapy On the Web |
|
American Roentgen Ray Society Images of Sporotrichosis medical therapy |
|
Risk calculators and risk factors for Sporotrichosis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Treatment
| Form | Primary Line of Treatment | Alternative Treatment | Remarks/Other |
|---|---|---|---|
| Uncomplicated cutaneous | Itraconazole [200 mg/day] | Itraconazole [200 b.i.d.],
terbinafine [500 b.i.d.], SSKI [increasing doses], fluconazole [400-800 mg/day], or local hyperthermia |
Continue treatment for 2-4 weeks after lesions resolve. |
| Osteoarticular | Itraconazole [200 mg b.i.d.] | Limposomal amphotericin B [3-5 mg/kg/day] or deoxycholate amphotericin B [0.7-1 mg/kg/day] until symptom resolution | For a total of 12 months, switch to itraconazole after resolution/end of treatment. |
| Pulmonary | |||
| Meningeal | |||
| Dissimated | |||
| Sporotrichosis in pregnant women | |||
| Sporotrichosis in Children |